Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Leukemia
|
February 19, 2020
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group
Huangming Hong, Yexiong Li, Soon Thye Lim, et al.
JAMA Oncology
|
July 13, 2023
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study
Wei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, et al.
Blood
|
January 3, 2024
Single-cell landscape of idiopathic multicentric Castleman disease in identical twins
Jason Yongsheng Chan, Jui Wan Loh, Jing Quan Lim, et al.
Leukemia & Lymphoma
|
December 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study
Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, et al.
Blood
|
May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
Tyler A Herek, Alyssa Bouska, Waseem Lone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Waseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
The Journal of Clinical Investigation
|
November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Cancer Letters
|
September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma
Yichen Sun, Yan Gao, Jianfeng Chen, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
JCO Global Oncology
|
October 5, 2020
Understanding the Psychological Impact of COVID-19 Pandemic on Patients With Cancer, Their Caregivers, and Health Care Workers in Singapore
Kennedy Yao Yi Ng, Siqin Zhou, Sze Huey Tan, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Leukemia
|
February 19, 2020
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group
Huangming Hong, Yexiong Li, Soon Thye Lim, et al.
JAMA Oncology
|
July 13, 2023
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study
Wei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, et al.
Blood
|
January 3, 2024
Single-cell landscape of idiopathic multicentric Castleman disease in identical twins
Jason Yongsheng Chan, Jui Wan Loh, Jing Quan Lim, et al.
Leukemia & Lymphoma
|
December 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study
Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, et al.
Blood
|
May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
Tyler A Herek, Alyssa Bouska, Waseem Lone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Waseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
The Journal of Clinical Investigation
|
November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Cancer Letters
|
September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma
Yichen Sun, Yan Gao, Jianfeng Chen, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
JCO Global Oncology
|
October 5, 2020
Understanding the Psychological Impact of COVID-19 Pandemic on Patients With Cancer, Their Caregivers, and Health Care Workers in Singapore
Kennedy Yao Yi Ng, Siqin Zhou, Sze Huey Tan, et al.
Page
of 19